You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy

Article metrics

Article menu
XML
Basic tumor immunology
Original research
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy

 

Online download statistics by month:

Online download statistics by month: October 2020 to July 2025

AbstractFullPdf
Oct 2020317317177
Nov 2020311311192
Dec 2020243243102
Jan 202126226281
Feb 202120820866
Mar 2021306306102
Apr 2021269269107
May 202118418472
Jun 202110910965
Jul 202110510566
Aug 2021156156122
Sep 202111411488
Oct 202110910983
Nov 2021116116114
Dec 202111912382
Jan 202213314189
Feb 2022797949
Mar 202214915586
Apr 202215316587
May 202213413574
Jun 202210010382
Jul 202210310678
Aug 2022707051
Sep 20229698113
Oct 202212713293
Nov 2022737453
Dec 2022919162
Jan 2023797936
Feb 202311411639
Mar 202313814175
Apr 202311411549
May 2023838454
Jun 2023595932
Jul 2023616143
Aug 2023515124
Sep 2023515121
Oct 2023565634
Nov 2023636436
Dec 2023707146
Jan 2024565837
Feb 2024626225
Mar 2024758238
Apr 2024585923
May 2024565731
Jun 2024706849
Jul 2024828334
Aug 2024807627
Sep 202447471125
Oct 20244850154
Nov 2024646429
Dec 202410210761
Jan 2025717156
Feb 2025888873
Mar 2025676871
Apr 2025869261
May 2025878769
Jun 2025686846
Jul 2025110
Total644365174934